1. Home
  2. ZIONP vs KLTOW Comparison

ZIONP vs KLTOW Comparison

Compare ZIONP & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZIONP
  • KLTOW
  • Stock Information
  • Founded
  • ZIONP N/A
  • KLTOW N/A
  • Country
  • ZIONP United States
  • KLTOW United States
  • Employees
  • ZIONP 9406
  • KLTOW 3
  • Industry
  • ZIONP Major Banks
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZIONP Finance
  • KLTOW Health Care
  • Exchange
  • ZIONP Nasdaq
  • KLTOW Nasdaq
  • Market Cap
  • ZIONP N/A
  • KLTOW N/A
  • IPO Year
  • ZIONP N/A
  • KLTOW 2022
  • Fundamental
  • Price
  • ZIONP $22.35
  • KLTOW $0.26
  • Analyst Decision
  • ZIONP
  • KLTOW
  • Analyst Count
  • ZIONP 0
  • KLTOW 0
  • Target Price
  • ZIONP N/A
  • KLTOW N/A
  • AVG Volume (30 Days)
  • ZIONP N/A
  • KLTOW N/A
  • Earning Date
  • ZIONP N/A
  • KLTOW N/A
  • Dividend Yield
  • ZIONP N/A
  • KLTOW N/A
  • EPS Growth
  • ZIONP N/A
  • KLTOW N/A
  • EPS
  • ZIONP N/A
  • KLTOW N/A
  • Revenue
  • ZIONP N/A
  • KLTOW N/A
  • Revenue This Year
  • ZIONP N/A
  • KLTOW N/A
  • Revenue Next Year
  • ZIONP N/A
  • KLTOW N/A
  • P/E Ratio
  • ZIONP N/A
  • KLTOW N/A
  • Revenue Growth
  • ZIONP N/A
  • KLTOW N/A
  • 52 Week Low
  • ZIONP N/A
  • KLTOW N/A
  • 52 Week High
  • ZIONP N/A
  • KLTOW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ZIONP 40.10
  • KLTOW N/A
  • Support Level
  • ZIONP $22.08
  • KLTOW N/A
  • Resistance Level
  • ZIONP $22.49
  • KLTOW N/A
  • Average True Range (ATR)
  • ZIONP 0.17
  • KLTOW 0.00
  • MACD
  • ZIONP -0.05
  • KLTOW 0.00
  • Stochastic Oscillator
  • ZIONP 16.43
  • KLTOW 0.00

About ZIONP Zions Bancorporation N.A.

Zions Bancorporation is a regional US bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions focuses primarily on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: